articleNew England Journal of MedicineMay 11, 2011BRONZE OA

FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer

TCThierry ConroyFDFrançoise DesseigneMYMarc YchouOBOlivier BouchéRGRosine Guimbaud

Centre de Recherche en Automatique de Nancy · Centre Léon Bérard · +16 more institutions

Indexed incrossref

Abstract

International audience

Citation impact

7,710
total citations
FWCI
136.12
Percentile
100%
References
37
Citations per year

Authors

20

Topics & keywords

Topics
Keywords
  • FOLFIRINOX
  • Gemcitabine
  • Irinotecan
  • Oxaliplatin
  • Medicine
  • Oncology
  • Regimen
  • Pancreatic cancer
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.